Citation

Ram D, Gowdappa B, Ashoka HG, Eiman N. Indian J. Pharmacol. 2015; 47(5): 484-490.

Affiliation

Department of Psychiatry, JSS Medical College, JSS University, Mysore, Karnataka, India.

Copyright

(Copyright © 2015, Medknow Publications)

DOI

10.4103/0253-7613.165186

PMID

26600635

PMCID

PMC4621667

Abstract

"Psychopharmacoteratophobia is the fear or avoidance of prescribing psychotropic medicine to a pregnant woman on a given indication in anticipation of fetal malformation." It is rooted in the tragedy associated with thalidomide use and is increasing due to the inability to predict accurately, strict legal provision of consumer protection, ethical and legal issues involved, and pitfalls in the available evidence of teratogenicity. In the Indian setting, the physicians face more challenges as the majority of the patients may ask them to decide, what is the best for their health. Most guidelines emphasize more on what not to do than what to do, and the locus of decision is left to the doctor and the patient. In this review, we have focused on relevant issues related to psychopharmacoteraophobia that may be helpful to understand this phenomenon and help to address the deprivation of a mentally ill woman from the required treatment.

Language: en